Prostate carcinoma Biopsy Positive | Disease TNM clinical staging | Biopsy sample Available Biomarker Analysis
Item
prostate biopsy positive for cancer; clinically localized t1 and t2 stage disease expected, with biopsy specimen available for baseline biomarker measurements
boolean
C0600139 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C1514241 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
C0677862 (UMLS CUI [3,1])
C0470187 (UMLS CUI [3,2])
C1879847 (UMLS CUI [3,3])
Scheduled Radical prostatectomy
Item
scheduled for a radical prostatectomy
boolean
C0205539 (UMLS CUI [1,1])
C0194810 (UMLS CUI [1,2])
Informed Consent | Protocol Compliance
Item
willing to sign an institutional review board (irb)-approved informed consent document and adhere to the protocol
boolean
C0021430 (UMLS CUI [1])
C0525058 (UMLS CUI [2])
Able to swallow oral medication
Item
willing and able to take oral medications
boolean
C2712086 (UMLS CUI [1,1])
C0175795 (UMLS CUI [1,2])
Tea Drinking To be stopped | Herbal Tea Drinking To be stopped | Supplement Containing Green tea Constituents
Item
willing to refrain from drinking any kind of tea (including herbal tea) or using supplements containing green tea constituents for the duration of the study
boolean
C0039400 (UMLS CUI [1,1])
C0684271 (UMLS CUI [1,2])
C1272691 (UMLS CUI [1,3])
C0019233 (UMLS CUI [2,1])
C0684271 (UMLS CUI [2,2])
C1272691 (UMLS CUI [2,3])
C2348609 (UMLS CUI [3,1])
C0332256 (UMLS CUI [3,2])
C1384640 (UMLS CUI [3,3])
C0729650 (UMLS CUI [3,4])
Hormone Therapy Prostate carcinoma | Operative Surgical Procedures Prostate carcinoma | Brachytherapy | Therapeutic radiology procedure
Item
prior hormonal or surgical therapy for prostate cancer; including prior brachytherapy or radiation therapy
boolean
C0279025 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C0543467 (UMLS CUI [2,1])
C0600139 (UMLS CUI [2,2])
C0006098 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
Consumption Tea cups/day | Supplement Containing Green tea
Item
recent consumption of tea (six or more cups per day) or use of supplements containing green tea within one week of randomization
boolean
C0009830 (UMLS CUI [1,1])
C0039400 (UMLS CUI [1,2])
C0560654 (UMLS CUI [1,3])
C2348609 (UMLS CUI [2,1])
C0332256 (UMLS CUI [2,2])
C1384640 (UMLS CUI [2,3])
Sign or Symptom | Kidney Diseases Progressive | Liver diseases Progressive | Hematological Disease Progressive | Endocrine System Diseases Progressive | Lung diseases Progressive | Heart Diseases Progressive | Nervous system disorder Progressive | Cerebral disorder Progressive | Kidney Diseases Uncontrolled | Liver diseases Uncontrolled | Hematological Disease Uncontrolled | Endocrine System Diseases Uncontrolled | Lung diseases Uncontrolled | Heart Diseases Uncontrolled | Nervous system disorder Uncontrolled | Cerebral disorder Uncontrolled
Item
signs or symptoms of progressive or uncontrolled renal, hepatic, hematologic, endocrine, pulmonary, cardiac, neurologic or cerebral disease
boolean
C3540840 (UMLS CUI [1])
C0022658 (UMLS CUI [2,1])
C0205329 (UMLS CUI [2,2])
C0023895 (UMLS CUI [3,1])
C0205329 (UMLS CUI [3,2])
C0018939 (UMLS CUI [4,1])
C0205329 (UMLS CUI [4,2])
C0014130 (UMLS CUI [5,1])
C0205329 (UMLS CUI [5,2])
C0024115 (UMLS CUI [6,1])
C0205329 (UMLS CUI [6,2])
C0018799 (UMLS CUI [7,1])
C0205329 (UMLS CUI [7,2])
C0027765 (UMLS CUI [8,1])
C0205329 (UMLS CUI [8,2])
C0234387 (UMLS CUI [9,1])
C0205329 (UMLS CUI [9,2])
C0022658 (UMLS CUI [10,1])
C0205318 (UMLS CUI [10,2])
C0023895 (UMLS CUI [11,1])
C0205318 (UMLS CUI [11,2])
C0018939 (UMLS CUI [12,1])
C0205318 (UMLS CUI [12,2])
C0014130 (UMLS CUI [13,1])
C0205318 (UMLS CUI [13,2])
C0024115 (UMLS CUI [14,1])
C0205318 (UMLS CUI [14,2])
C0018799 (UMLS CUI [15,1])
C0205318 (UMLS CUI [15,2])
C0027765 (UMLS CUI [16,1])
C0205318 (UMLS CUI [16,2])
C0234387 (UMLS CUI [17,1])
C0205318 (UMLS CUI [17,2])
Serum creatinine raised
Item
serum creatinine >= 1.5 x upper limit of normal (uln)
boolean
C0700225 (UMLS CUI [1])
Alanine aminotransferase measurement
Item
alanine aminotransferase (alt) >= uln
boolean
C0201836 (UMLS CUI [1])
Aspartate aminotransferase measurement
Item
aspartate aminotransferase (ast) >= uln
boolean
C0201899 (UMLS CUI [1])
Alkaline phosphatase measurement
Item
alkaline phosphatase (alp) >= uln
boolean
C0201850 (UMLS CUI [1])
Albumin measurement
Item
albumin (alb) =< lower limit of normal (lln)
boolean
C0201838 (UMLS CUI [1])
Serum total bilirubin measurement
Item
total bilirubin >= uln
boolean
C1278039 (UMLS CUI [1])
Malignant Neoplasm Site Any | Basal cell carcinoma Excluded
Item
known malignancy at any site within the last five years; with the exception of basal cell carcinoma (bcc)
boolean
C0006826 (UMLS CUI [1,1])
C1515974 (UMLS CUI [1,2])
C1552551 (UMLS CUI [1,3])
C0007117 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
Study Subject Participation Status
Item
participation in a research trial within the past three months
boolean
C2348568 (UMLS CUI [1])
Condition Interferes with Informed Consent | Condition Interferes with Protocol Compliance
Item
any condition that would interfere with the ability to give informed consent or comply with the study protocol
boolean
C0348080 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0525058 (UMLS CUI [2,3])
Hypersensitivity Tea product | Hypersensitivity Tea product Inactive ingredient
Item
hypersensitivity to tea products or any of the inactive ingredients found in the drug product capsules
boolean
C0020517 (UMLS CUI [1,1])
C0039400 (UMLS CUI [1,2])
C1514468 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C0039400 (UMLS CUI [2,2])
C1514468 (UMLS CUI [2,3])
C1552019 (UMLS CUI [2,4])
Non-Steroidal Anti-Inflammatory Agents U/day Frequency
Item
concomitant use of at least 400 mg per day of a nonsteroidal anti-inflammatory (nsaid) agent two or more times per week
boolean
C0003211 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0439603 (UMLS CUI [1,3])